A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2

Recent genetic studies have identified common variation in susceptibility loci that stratify lifetime risks of breast cancer and may inform prevention and screening strategies. However, whether these loci have similar implications for women treated with tamoxifen or raloxifene (SERMs) is unknown. We...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Breast Cancer Res Treat
Päätekijät: Vachon, Celine M., Schaid, Daniel J., Ingle, James N., Wickerham, D. Lawrence, Kubo, Michiaki, Mushiroda, Taisei, Goetz, Matthew P., Carlson, Erin E., Paik, Soonmyung, Wolmark, Norman, Nakamura, Yusuke, Wang, Liewei, Weinshilboum, Richard, Couch, Fergus J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4327931/
https://ncbi.nlm.nih.gov/pubmed/25575444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-3175-4
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia